Radiosensitizers and Radiochemotherapy in the Treatment of Cancer catalogs and describes the mechanism of action for entities characterized as radiosensitizers. Developments in the biological and physical sciences have introduced new radiosensitizers and defined novel targets for radiosensitization. As a result, a book about radiosensitization must now address a huge range of topics, covering everything from molecular oxygen and high Z elements to monoclonal antibodies and complex phytochemicals. At the molecular level, the understanding of the molecular consequences of DNA damage and the DNA damage response have informed the development of targeted radiosensitizers and shed light on the mode of action of radiochemotherapy protocols of known clinical efficacy. In this book the mechanisms of action at the molecular and cellular level are described for documented radiosensitizers including, where applicable, a brief history of their clinical use and most recent clinical results. In addition, the clinical context is addressed including the importance of factors such as dose and dose rate, normal tissue toxicity, and drug delivery. Intuitively organized by topic and application, the book includes extensive illustrations, end-of-chapter summaries, and a wealth of references.
This book presents state-of-the-art diagnoses and treatments available for bladder cancer that has metastasised into the body.
Rectal cancer is one of the most prevalent cancers world-wide. It is also a paradigm for multimodal management, as the combination of surgery, chemotherapy and radiotherapy is often necessary to achieve the optimal outcome.
Thoroughly revised and updated, the 2nd Edition presents all of the latest advances in the field, including the most recent technologies and techniques.
Cancer treatment is complex and calls for a diverse set of services. Radiotherapy is recognized as an essential tool in the cure and palliation of cancer.
J Clin Oncol 3(10):1296–1300, 1985. Bierman PJ, et al: Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poorprognosis Hodgkin's disease. J Clin Oncol 11(4):698–703, 1993.
Brain Metastases from Primary Tumors Volume 1 fills that gap, serving as the first reference to focus primarily on the link between primary cancers and brain metastases.
Molecular biology: oncogenes and tumor suppressor genes /Kathleen M. Diehl and Kathleen M. Woods Ignatoski --Cellular biology: tumor growth and metastasis /Michael S. Sabel --Basic epidemiologic methods for cancer investigations...
... patients with biopsyproven endometriosisa Pelvic site No. with involvement (%) Cul-de-sac 1521 (71.9) Left broad ... 476 patients with obliteration of the cul-de-sac or stage IV disease have been excluded because most patients do ...
Gold nanoparticles provide a platform for the development of new and efficient diagnostic and therapeutic tools.This book offers a general guide to the synthesis and coating of gold nanoparticles.
This book provides a comprehensive overview of brain metastases, from the molecular biology aspects to therapeutic management and perspectives.